Helen Alix Fiona Nicole Elmie Lisa Rigel Milroy Woolard Wood Wickens Janse Van Rensburg McGivern Paciente HM AW FW NW EJVR LM RP MBBS; FRANZCP; CATCAP BPsych (Hons), PhD BHlthSc (Hons) BA, BSc BA (Hons 1, Psych) MPH (Applied Public Health and Public ...

• 1. Telethon Kids Institute
• Projects

Measures of allergic sensitization and therapeutic strategies could be optimized with knowledge of Der p 2 variants ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2016
• January 2016

Valerie Verhasselt VV MD, PhD Head, Immunology and Breastfeeding 0402997617 Valerie.verhasselt@telethonkids.org.au Head, Immunology and Breastfeeding @valerieverhass1 Professor Verhasselt is Head of Immunology and Breast Feeding at the Telethon ...

• 1. Telethon Kids Institute
• Projects

The interaction between genotype and Epstein Barr virus emerges as relevant for multiple sclerosis etiology. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2013
• May 2013

Although many mothers initiate breastfeeding, supplementation with human-milk substitutes (formula) during the birth hospitalization is common and has been associated with early breastfeeding cessation. Colostrum hand expressed in the last few weeks before birth, known as antenatal colostrum expression (ACE), can be used instead of human-milk substitutes. However, evidence is lacking on the efficacy of ACE on breastfeeding outcomes and in non-diabetic mothers.  ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• December 2023

Glenn Martyn Pearson Symons G MS BA (Education) PhD Candidate B.A. (Hons) PhD. Director of First Nations Strategy and Leadership Honorary Research Associate 08 6319 1672 martyn.symons@telethonkids.org.au Director of First Nations Strategy and ...

• 1. Telethon Kids Institute
• Projects

Repurposed drugs with host-directed antiviral and immunomodulatory properties have shown promise in the treatment of COVID-19, but few trials have studied combinations of these agents. The aim of this trial was to assess the effectiveness of affordable, widely available, repurposed drugs used in combination for treatment of COVID-19, which may be particularly relevant to low-resource countries.  ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2024
• March 2024

Alexander David Martyn Larcombe Martino Symons A DM MS BScEnv (Hons) PhD BSc PhD B.A. (Hons) PhD. Team Leader, Respiratory Environmental Health Head, Clinical Epigenetics Honorary Research Associate 08 6319 1672 David.Martino@telethonkids.org.au ...

• 1. Telethon Kids Institute
• Projects

The results suggest that timely injection and patient education are priorities for managing ARF and RHD, particularly focusing on child-to-adult transition care ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• January 2020

Our results indicate a dissociation between the antibody and T-cell responses to rhinoviruses ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2016
• November 2016

Christopher Blyth CC MBBS (Hons) DCH FRACP FRCPA PhD Director, Wesfarmers Centre of Vaccines and Infectious Diseases; Co-Head, Infectious Diseases Epidemiology, Wesfarmers Centre of Vaccines and Infectious Diseases, Honorary and NHMRC Emerging ...

• 1. Telethon Kids Institute
• Projects

Recurrences frequently occur following surgical removal of primary tumors. In many cancers, adjuvant therapies have limited efficacy. Surgery provides access to the tumor microenvironment, creating an opportunity for local therapy, in particular immunotherapy, which can induce local and systemic anti-cancer effects. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2023
• July 2023